CONMED's shares are directly impacted by the company's financial performance. The worse-than-expected Q4 results have led to a negative reaction in the stock market, indicating a direct correlation between the earnings report and the company's stock price movement. This is a common market response to earnings misses, as investors adjust their expectations based on the company's reported financial health.